Topical Skin Composition for Reducing Wrinkles and Pigmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current skin care products fail to effectively address skin aging and pigmentation issues while often causing skin irritation, and existing treatments for extrinsic and intrinsic aging have safety concerns and limited efficacy.

Innovation Solution

A topical skin composition combining Rhododendron ferrugineum extract, Oenothera biennis extract, and a biomimetic peptide, along with a cosmetic vehicle, to counter oxidative and inflammatory damage, increase dermal protein production, reduce pigmentation, and inhibit progerin accumulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional depigmenting agents (hydroquinone, corticosteroids, kojic acid) are used to treat pigmentation, then pigmentation is reduced, but skin safety deteriorates due to side effects like ochronosis, atrophy, and carcinogenesis

Engineering Contradiction:
ImprovepigmentationVSAvoidskin safety
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent replaces conventional depigmenting agents with a combination of safer, more biocompatible ingredients including vitamin C derivatives (ascorbyl glucoside, ascorbyl palmitate), vitamin E (tocopherol), ferulic acid, and plant extracts. These ingredients have shorter action pathways and fewer cumulative toxic effects compared to hydroquinone and corticosteroids, achieving pigmentation reduction without the severe side effects of conventional agents

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention uses a composite formulation combining multiple antioxidants and skin-conditioning agents (vitamin C derivatives, vitamin E, ferulic acid, hyaluronic acid, aloe vera extract, green tea extract) that work synergistically to reduce pigmentation through multiple mechanisms while maintaining skin safety. This composite approach distributes the functional load across multiple gentle ingredients rather than relying on a single harsh agent

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If topical treatments are applied to address skin aging, then skin appearance is improved, but skin irritation increases

Engineering Contradiction:
Improveskin aging signsVSAvoidskin irritation
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent modifies the chemical parameters of active ingredients by using derivatives with improved safety profiles: vitamin C is converted to ascorbyl glucoside and ascorbyl palmitate (more stable and gentler forms), and the formulation controls pH and concentration levels to minimize irritation while maintaining efficacy against aging signs

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The formulation applies different functional ingredients to address specific aging concerns in different skin layers: antioxidants (vitamin C derivatives, vitamin E, ferulic acid) protect against oxidative damage, hyaluronic acid provides hydration in the epidermis, and retinol penetrates deeper to stimulate collagen production, thereby treating aging signs locally without causing uniform irritation across the skin

Inventive Principle:
Principle #3Local quality

3Object-affected harmful factors

If existing treatments for intrinsic and extrinsic aging are used, then some aging signs are addressed, but efficacy is limited and safety concerns arise

Engineering Contradiction:
Improveskin agingVSAvoidtreatment safety and efficacy
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent segments the complex problem of skin aging into distinct treatable components: oxidative stress (addressed by vitamin C derivatives, vitamin E, ferulic acid), inflammation (addressed by aloe vera extract, green tea extract, hibiscus extract), collagen degradation (addressed by retinol and copper peptides), and hydration loss (addressed by hyaluronic acid). This segmentation allows targeted treatment of each aging mechanism with specialized ingredients, improving both efficacy and safety compared to broad-spectrum treatments

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20240325816A1Cosmetic compositions
Publication Date: 2024.10.03 MARY KAY INC
  • US20240325816A1 patent drawing

AI summary

A method of reducing the appearance of fine lines or wrinkles on a person's skin is disclosed. The method includes topically applying to the fine lines or wrinkles a composition comprising: oenothera biennis extract; adenosine; caprylic/capric triglyceride; glycerin; dimethicone; cetearyl alcohol; glyceryl sterate; hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer; cetyl alcohol; sunflower (helianthus annuus) seed oil; and sodium hyaluronate.